Ibrahim Ince results 5
· Newest (Page 1/1, per page 25)
Author: Ibrahim Ince ×Clear All Filters
Search Results
The antiparasitic drug nifurtimox was approved in the USA in 2020 for the treatment of patients with Chagas disease aged less than 18 years and weighing at least 2.5 kg, based on outcomes from the phase 3 CHICO study. Accordingly, pediatric patients with Chagas disease take nifurtimox thrice daily with food at one of two body weight–adjusted dose ranges. We investigated possible relationships between pharmacokinetic (PK) data,...
Previous1Next